<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05055336</url>
  </required_header>
  <id_info>
    <org_study_id>20210662</org_study_id>
    <nct_id>NCT05055336</nct_id>
  </id_info>
  <brief_title>Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia</brief_title>
  <official_title>Longitudinal Evaluation of Gastric Emptying and Accommodation in Children With Dyspepsia: Toward Individualized Care in Functional Abdominal Pain Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Miami</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Neurogastroenterology and Motility Society</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Miami</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to further study the relationship between gastroparesis (GP)&#xD;
      (a condition in which the stomach cannot empty itself of food in a normal fashion) and&#xD;
      functional dyspepsia (FD) (frequent symptoms of indigestion that have no obvious cause).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">April 1, 2023</completion_date>
  <primary_completion_date type="Anticipated">April 1, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Gastric emptying rate</measure>
    <time_frame>up to 6 months</time_frame>
    <description>As measured by the spirulina breath test</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Percentage of food retained in the stomach</measure>
    <time_frame>Day 1</time_frame>
    <description>Fundic accommodation will be reported as the percentage of food retained in the fundus using an ultrasound before and after meal ingestion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric Cardinal Symptoms Questionnaire Scores</measure>
    <time_frame>Up to 6 months</time_frame>
    <description>The pediatric symptoms questionnaires has a total score ranging from 0-600. Higher score means worse symptoms.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Gastroparesis</condition>
  <condition>Dyspepsia</condition>
  <arm_group>
    <arm_group_label>Gastroparesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group are children diagnosed with gastroparesis per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dyspepsia</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group are children diagnosed with functional dyspepsia per gastric emptying scintigraphy. Participants will be receiving a gastric emptying breath test three times over the course of 6 months and an ultrasound of the stomach once.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Controls</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants in this group are children that do not have gastroparesis, functional dyspepsia, or any other gastroenterology condition. Participants will be getting an ultrasound once.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Gastric emptying breath test</intervention_name>
    <description>The gastric emptying breath test is used to diagnose gastroparesis. Participants ingest spirulina in a meal and samples are taken every 45 minutes for 4 hours.</description>
    <arm_group_label>Dyspepsia</arm_group_label>
    <arm_group_label>Gastroparesis</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stomach ultrasound</intervention_name>
    <description>Ultrasound of the fundus of the stomach will be done immediately after ingestion of the test meal, at 15 minutes, and at 30 minutes.</description>
    <arm_group_label>Dyspepsia</arm_group_label>
    <arm_group_label>Gastroparesis</arm_group_label>
    <arm_group_label>Healthy Controls</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Able to complete the Pediatric Cardinal Symptoms Questionnaire&#xD;
&#xD;
          -  Both parent and child must be able to speak and understand English or Spanish&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Have global developmental delay, autism disorder, or psychosis&#xD;
&#xD;
          -  Are nonverbal and/or illiterate&#xD;
&#xD;
          -  Lack fluency in English or Spanish&#xD;
&#xD;
          -  Have other GI comorbidities such as inflammatory bowel disease, celiac disease,&#xD;
             eosinophilic esophagitis, peptic ulcer disease, GI malignancy, or gastroesophageal&#xD;
             reflux disease responsive to medications (medical records will be reviewed to detect&#xD;
             these exclusions)&#xD;
&#xD;
          -  Have a history of surgical procedures that could have potentially affected their GI&#xD;
             tract anatomy, such as fundoplication or Ladd's procedure.&#xD;
&#xD;
          -  Healthy child presenting to their well child care visit must not report a history of&#xD;
             dyspepsia, have a history of any gastrointestinal disease, or be taking any medication&#xD;
             that can disturb the GI tract motility.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liz Febo-Rodriguez, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Miami</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Liz Febo-Rodriguez, MD</last_name>
    <phone>305-243-3166</phone>
    <email>ljf17@med.miami.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Miami</name>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33136</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liz Febo-Rodriguez, MD</last_name>
      <phone>305-243-3166</phone>
      <email>ljf17@med.miami.edu</email>
    </contact>
    <investigator>
      <last_name>Liz Febo-Rodriguez, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>August 23, 2021</study_first_submitted>
  <study_first_submitted_qc>September 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 24, 2021</study_first_posted>
  <last_update_submitted>September 21, 2021</last_update_submitted>
  <last_update_submitted_qc>September 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Miami</investigator_affiliation>
    <investigator_full_name>Liz Febo-Rodriguez</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroparesis</mesh_term>
    <mesh_term>Dyspepsia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

